Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Exact Sciences Cor (EXAS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,708,727
  • Shares Outstanding, K 119,730
  • Annual Sales, $ 99,380 K
  • Annual Income, $ -167,210 K
  • 36-Month Beta 0.68
  • Price/Sales 25.20
  • Price/Cash Flow N/A
  • Price/Book 12.03

Price Performance

See More
Period Period Low Period High Performance
1-Month
45.02 +9.40%
on 01/17/18
57.84 -14.85%
on 01/05/18
-3.57 (-6.76%)
since 12/18/17
3-Month
45.02 +9.40%
on 01/17/18
63.60 -22.56%
on 11/08/17
+2.63 (+5.64%)
since 10/18/17
52-Week
16.95 +190.56%
on 01/25/17
63.60 -22.56%
on 11/08/17
+30.33 (+160.31%)
since 01/18/17

Most Recent Stories

More News
Watch for Exact Sciences to Potentially Rebound After Falling 11.31% Yesterday

Exact Sciences (NASDAQ:EXAS) traded in a range yesterday that spanned from a low of $45.02 to a high of $53.64. Yesterday, the shares fell 11.3%, which took the trading range below the 3-day low of $52.00...

EXAS : 49.11 (+3.00%)
Today's Research Reports on Stocks to Watch: Concert Pharmaceuticals and Exact Sciences Corporation

NEW YORK, NY / ACCESSWIRE / January 15, 2018 / Concert Pharmaceuticals shares crumbled on Friday after it was revealed that the company's CTP-543 treatment could infringe on Incyte's patent and after...

CNCE : 19.78 (-0.80%)
EXAS : 49.11 (+3.00%)
INCY : 92.55 (+2.48%)
Exact Sciences Announces Upsize and Pricing of $600 Million of 1.0% Convertible Senior Notes Due 2025

Exact Sciences Corporation (NASDAQ: EXAS) announced today that it has priced its underwritten public offering of 1.0% convertible senior notes due 2025 (the "Notes"), and upsized the offering from $500...

EXAS : 49.11 (+3.00%)
Exact Sciences (EXAS) in Focus: Stock Moves 5.1% Higher

The shares of Exact Sciences (EXAS) rose over 5% yesterday.

EXAS : 49.11 (+3.00%)
EBS : 49.74 (-0.18%)
Today's Research Reports on Stocks to Watch: ACADIA Pharmaceuticals Inc. and Exact Sciences Corporation

NEW YORK, NY / ACCESSWIRE / January 9, 2018 / It was a day of losses for ACADIA on Monday, closing the day down a little over 6% at $27.11. There was no major news from the company whose stock was trading...

EXAS : 49.11 (+3.00%)
ACAD : 28.02 (-0.81%)
Exact Sciences to report $265.5-266.5 million in revenue, 168 percent growth for 2017

Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company expects to report revenue between $86.9 million and $87.9 million for the fourth quarter ended Dec. 31, 2017, an increase of 148 percent...

EXAS : 49.11 (+3.00%)
Life Sciences Pioneer Stanley Lapidus Joins Atlas Genetics Board of Directors

Atlas Genetics, a rapid, near-patient and point-of-care (POC) testing company, today announced that it has appointed Stanley Lapidus to the role of independent board member on its Board of...

HOLX : 43.96 (-0.09%)
EXAS : 49.11 (+3.00%)
Exact Sciences Set to Possibly Rebound After Yesterday's Selloff of 2.55%

Exact Sciences (NASDAQ:EXAS) traded in a range yesterday that spanned from a low of $49.46 to a high of $52.56. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $51.56...

EXAS : 49.11 (+3.00%)
Exact Sciences to participate in J.P. Morgan Healthcare Conference

Exact Sciences Corp. (Nasdaq: EXAS) today announced that its executives will be presenting at the following investor conference and invited investors to participate by webcast.

EXAS : 49.11 (+3.00%)
JPM : 113.24 (+0.22%)
Exact Sciences Set to Possibly Pullback After Yesterday's Rally of 1.64%

Exact Sciences (NASDAQ:EXAS) traded in a range yesterday that spanned from a low of $52.98 to a high of $53.97. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of...

EXAS : 49.11 (+3.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

See More

Business Summary

EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings for a stool-based DNA screening assay for colorectal cancer in...

See More

Key Turning Points

2nd Resistance Point 57.40
1st Resistance Point 52.54
Last Price 49.09
1st Support Level 43.92
2nd Support Level 40.16

See More

52-Week High 63.60
Last Price 49.09
Fibonacci 61.8% 45.78
Fibonacci 50% 40.28
Fibonacci 38.2% 34.77
52-Week Low 16.95

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.